A Randomized Phase III Study Evaluating Modified FOLFIRINOX (mFFX) With or Without Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Locally Advanced Pancreatic Cancer
The goal of this study is to determine the safety and efficacy of a chemotherapy regimen
known as Modified FOLFIRINOX (mFFX) alone or with the addition of Stereotactic Body
Radiation Therapy (SBRT). We hope to learn if this new treatment combination helps to control the
disease and improve survival for patients with locally advanced pancreatic cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society